Paulina Haight

Paulina Haight's research focuses on gynecologic cancers, especially ovarian and endometrial cancer, examining treatment sequencing, molecular markers (such as MLH1 and TP53 mutations), and outcomes tied to specific drug therapies like mirvetuximab soravtansine, pembrolizumab, and lenvatinib. The work also includes health-services topics such as cost-effectiveness of cancer treatments and clinical workflow/efficiency in gynecologic oncology surgical training. This research is largely clinical and translational, drawing on real-world patient cohort data.

Publication output has grown substantially over the past decade, rising from occasional single papers before 2021 to a sustained pace of over a dozen publications per year from 2023 onward.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026